- Report
- June 2025
- 287 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2024
- 219 Pages
Global
From €3232EUR$3,600USD£2,753GBP
- Report
- June 2024
- 99 Pages
Asia Pacific
From €1347EUR$1,500USD£1,147GBP
- Report
- June 2024
- 86 Pages
North America
From €1347EUR$1,500USD£1,147GBP
- Report
- June 2024
- 97 Pages
Africa, Middle East
From €1347EUR$1,500USD£1,147GBP
- Report
- June 2024
- 99 Pages
Europe
From €1347EUR$1,500USD£1,147GBP
- Report
- May 2025
- 182 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 198 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- October 2024
- 188 Pages
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 188 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- May 2025
- 175 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- April 2025
- 175 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- March 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- February 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- April 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- April 2025
- 200 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- March 2025
- 175 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- May 2024
- 140 Pages
Global
From €5835EUR$6,499USD£4,969GBP
- Report
- February 2024
- 185 Pages
Global
From €3434EUR$3,825USD£2,925GBP
€4040EUR$4,500USD£3,441GBP
- Report
- April 2023
- 120 Pages
Global
From €4265EUR$4,750USD£3,632GBP

Rabeprazole is a proton pump inhibitor (PPI) used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease. It is also used to reduce the risk of gastric ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Rabeprazole works by blocking the production of acid in the stomach, which helps to reduce symptoms of acid reflux and other gastrointestinal disorders.
Rabeprazole is available in both generic and brand-name formulations. It is typically taken once daily, and is available in tablet, capsule, and oral suspension forms. Common side effects of rabeprazole include headache, nausea, diarrhea, and abdominal pain.
Rabeprazole is one of the most commonly prescribed PPIs for the treatment of gastrointestinal disorders. It is widely available in pharmacies and is covered by most insurance plans.
Some companies that produce rabeprazole include Dr. Reddy's Laboratories, Sun Pharmaceutical Industries, and Teva Pharmaceuticals. Show Less Read more